ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Hennezel, L.
Right arrow Articles by Calvet, J-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Hennezel, L.
Right arrow Articles by Calvet, J-H.
European Respiratory Journal 17:94-99 (2001)
© 2001 ERS Journals Ltd


Plethysmography for the assessment of pneumococcal pneumonia and passive immunotherapy in a mouse model

L. de Hennezel4, S. Debarre1, F. Ramisse2, S. Delamanche1, A. Harf3, J-M. Alonso4 and J-H. Calvet1

1 Laboratoire de Toxicologie Respiratoire and 2 Laboratoire de Microbiologie, Centre d'Etudes du Bouchet (Defense Medical Research Center), Vert-Le-Petit, 91710, 3 INSERM U492, Créteil and 4 Unité des Neisseria, Institut Pasteur, France

CORRESPONDENCE: J-M. Alonso, Dept of Bacteriology and Mycology, Institut Pasteur, 25–28 Rue du Docteur Roux, 75724, Paris Cedex 15, France. Fax: 33 140613034

The increasing prevalence of resistance to antibiotics of Streptococcus pneumoniae, the main causative agent of community-acquired bacterial pneumonia, necessitates the development of both new therapeutic strategies and noninvasive methods in order to evaluate their efficacy.

The efficacy of passive immunotherapy with human intravenous immunoglobulin (IVIG) or solvent alone, administered intranasally or intravenously, was evaluated in a mouse model of acute pneumonia. Lung bacterial load was also evaluated, using a classical but invasive method, as was respiratory function (minute ventilation, respiratory frequency and tidal volume) using plethysmography, a simple noninvasive method commonly used in inhalation toxicology, but not previously used to assess respiratory infection.

Forty-eight hours after infectious challenge, the lung bacterial load was significantly lower in IVIG-treated mice than in untreated mice. At the same time, minute ventilation was significantly lower than reference values for untreated mice (36±3 versus 57±8 mL·min–1, p<0.01, and 31±2 versus 50±5 mL·min–1, p<0.01 for intranasal and intravenous administration of solvent, respectively) but not in mice treated with IVIG by either route of administration.

Plethysmography therefore appears to be a simple and reliable test for the follow-up of acute respiratory infection.

Keywords: mouse model, plethysmography, pneumonia







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the European Respiratory Society.